| Therapy | Proposed mechanism | Beginning dosage | Continuing dosage | Side effects | Precautions | Evidence |
|---|---|---|---|---|---|---|
| Oral therapies | ||||||
| Amitriptyline | Decreases neuronal hypersensitivity | 25 mg at bedtime for 10 days, then 50 mg at bedtime daily | 50 to 100 mg at bedtime (higher dosages to 225 mg occasionally are successful) | Dry mouth, fatigue (often transient), constipation, weight gain (uncommon) | Start at lower dosages in older patients. | Case reports9,38,39 |
| Retrospective reports9,39 | ||||||
| Calcium citrate | Decreases oxalate deposition in tissues | 2 tablets twice daily | 2 to 4 tablets twice daily | Minimal | Used in conjunction with other treatments. | Case reports40 |
| Anecdotal evidence when used in conjunction with a low-oxalate diet41 | ||||||
| Desipramine (Norpramin) | Decreases neuronal hypersensitivity | 25 mg at bedtime for 10 days, then 50 mg at bedtime daily | 50 to 100 mg at bedtime (higher dosages to 225 mg occasionally are successful) | Same as amitriptyline but less common | Start at lower dosages in older patients. | None. Based on similarity to amitriptyline and use in other painful neuropathies42 |
| Gabapentin (Neurontin) | Decreases neuronal hypersensitivity | 300 mg daily, increasing every five days by 300 mg per day (to three-times-per-day dosing) | 300 mg three times daily, to maximum of 900 mg three times daily (2,700 mg) | Headaches, nausea, vomiting, fatigue, and dizziness (often transient or mild)43 | — | Case reports suggest benefit.43 |
| Paroxetine (Paxil) | Decreases neuronal hypersensitivity | 10 mg daily | 20 to 60 mg daily | Rarely fatigue, anorgasmia, or weight gain | Discontinuation should be gradual. | Case reports9 |
| Venlafaxine (Effexor) | Decreases neuronal hypersensitivity | 37.5 mg daily | 75 to 150 mg daily | Anorgasmia, gastrointestinal side effects, anxiety | Blood pressure, electrolyte levels, and lipid levels should be monitored periodically. | Used in other painful neuropathies |
| Dietary changes | ||||||
| Low-oxalate diet | Decreases the possible role of oxalate deposition in vulvar tissue | Ranges from a highly oxalate-restrictive diet to avoidance of a short list of foods that increase oxalate levels significantly44 | — | A low-oxalate diet is very restrictive. If initiated, it should be continued only if clear benefits are noted. | — | The role of oxalates in vulvodynia is controversial.40,41 A case report40 suggested benefit when used in conjunction with calcium citrate supplementation. |
| Surgical therapy | ||||||
| Perineoplasty and vestibulectomy | Removal of hypersensitive tissue and replacement with vaginal mucosa advancement | — | — | Acute discomfort and job absenteeism. Rarely, bleeding, infection, hematoma, wound separation, vaginismus, vaginal stenosis | Only useful in localized (vestibular) cases. Most physicians reserve surgical treatment for patients who have not had success with other therapies. | Case series45,46 |
| Contolled treatment trial47 (70 percent response) | ||||||
| Topical therapies | ||||||
| Lidocaine gel or cream (5%) | Local anesthetic to decrease hypersensitivity | Apply topically to introitus. | Apply as needed before intercourse or nightly on a cotton ball in the introitus. | — | — | Case series48 |
| Cromolyn cream (4%) | Decreases possible mast cell degranulation in vulvar tissue | Apply three times daily to introitus. | Continue three-times-daily application to introitus. | — | Not commercially available; must be formulated in a bland cream or ointment. | Case report suggested benefit.49 |
| Blinded treatment trial49 suggested no improvement. | ||||||
| Avoidance of irritants (e.g., perfumes, harsh soaps, colored underwear, nylon) | Decreases exposure to foreign antigens and heat | — | — | — | — | Unknown efficacy50 |
| Other therapies | ||||||
| Biofeedback and/or physical therapy | Improves the electrodiagnostic pattern of pelvic floor musculature via biofeedback and muscle conditioning | Evaluation by physical therapist and instruction in home biofeedback exercises, with or without other physical therapy modalities and portable electromyographic feedback instrumentation | Continue home biofeedback daily for 16 weeks.47,51 Six to 16 physical therapy sessions, if used | Discomfort during treatment | Biofeedback requires home electromyographic monitor. Physical therapy typically uses instrumentation during therapy and exercises and stretching at home. | Nonblinded case series21,51 of biofeedback with six-month follow-up indicated benefit. |
| Controlled trial47 of biofeedback indicated 30 percent improvement. | ||||||
| Retrospective case series52 of physical therapy suggested improvement in most patients. | ||||||
| Cognitive behavioral therapy | Increases understanding of the disorder and encourages patients to find ways to minimize symptoms | Eight two-hour group sessions over 12 weeks | — | — | Recommended duration can be up to 1.5 years.53 | Randomized treatment trial47 (30 percent response) |